1. Articles in category: Acquisition

    1-24 of 60 1 2 3 »
    1. Canon in exclusive negotiations to acquire Toshiba Medical Systems for $6B

      Canon in exclusive negotiations to acquire Toshiba Medical Systems for $6B

      Canon has emerged as the exclusive bidder for Toshiba Medical Systems , beating out Fujifilm Holdings in the final round of discussions, and numerous others who were also reportedly interested, including Sony ( $SNE ), Konica Minolta and private equity players KKR, Bain Capital, the Carlyle Group and the U.K.'s Permira. Canon will have exclusive negotiating rights until March 18, during which the two sides will aim to hammer out the details of a final agreement, expected to be valued around ¥700 billion ($6 billion). "Toshiba has carried out a close evaluation of the overall proposals received from companies that expressed ...

      Read Full Article
    2. Axsun Technologies announces acquisition and growth capital investment by Anzu Partners

      Axsun Technologies announces acquisition and growth capital investment by Anzu Partners

      Axsun Technologies announced that it has been successfully divested from Volcano Corporation, a subsidiary of Royal Philips, and acquired by Anzu Partners, an investment firm based in Washington DC. As part of the transaction, Axsun received a significant infusion of growth capital and an affiliate of Anzu Partners purchased the 65,000 square foot building in Billerica, MA that houses Axsun’s operations. Axsun’s experienced management team will remain in place. Jonathan Hartmann, currently VP/GM will lead the newly independent Axsun as CEO. Peter Whitney will continue as Chief Science Officer and VP of Engineering, leading technology and ...

      Read Full Article
    3. Acquisition of Spin-out Company Bioptigen to Bring Duke Imaging Technology to New Markets

      Acquisition of Spin-out Company Bioptigen to Bring Duke Imaging Technology to New Markets

      In June 2015, microscopy and imaging systems company Leica Microsystems acquired Bioptigen Inc., a company born from Duke's Pratt School of Engineering. Formed in 2004, Bioptigen has become a leader in optical coherence tomography (OCT), an imaging technique that uses light to capture extremely high-resolution, three-dimensional pictures of the eye. Bioptigen was the brainchild of Duke’s Michael J. Fitzpatrick Professor of Engineering Joseph Izatt and CEO Eric Buckland. Since its launch, the company secured more than 60 issued patents in OCT technology, many of which were licensed from intellectual property developed by Izatt, his students, and collaborators at ...

      Read Full Article
    4. Leica Microsystems buys Duke medical imaging spinout Bioptigen

      Leica Microsystems buys Duke medical imaging spinout Bioptigen

      A buyout announcement today from Morrisville medical imaging company Bioptigen is the latest evidence that support from the North Carolina Biotechnology Center can be important. The 2004 Duke University spinout, which makes specialized high-resolution imaging devices for non-invasive diagnoses of eye diseases and other medical applications, has reached agreement to be purchased by German powerhouse Leica Microsystems. Leica Microsystems, based in Wetzlar, Germany, a global leader in microscopy and imaging systems, said it’s buying Bioptigen to strengthen its position in the ophthalmology market. Bioptigen is a technology leader in the field of optical coherence tomography (OCT), a form of ...

      Read Full Article
    5. Leica Microsystems to Acquire OCT Company Bioptigen

      Leica Microsystems to Acquire OCT Company Bioptigen

      Integration of Optical Coherence Tomography (OCT) Opens up New Avenues for Ophthalmology and Life Science Research Leica Microsystems, a global leader in microscopy and imaging systems, has signed a definitive agreement to acquire Bioptigen, Inc. to strengthen its position in the ophthalmology market. Bioptigen is a technology leader in the field of optical coherence tomography (OCT). The integration of OCT imaging into Leica Microsystems’ surgical microscopes will assist ophthalmologists during eye surgery. Bioptigen develops and manufactures innovative OCT systems and software and is globally successful with products for clinical as well as translational research applications. Using low-power, near-infrared light, Bioptigen ...

      Read Full Article
    6. Law Firm Launches Investigation of the Board of Directors of Volcano Corporation Regarding the Fairness of the Sale of the Company to Royal Philips

      Law Firm Launches Investigation of the Board of Directors of Volcano Corporation Regarding the Fairness of the Sale of the Company to Royal Philips

      Levi & Korsinsky is investigating the Board of Directors of Volcano Corporation ("Volcano" or "the Company") (Nasdaq: VOLC ) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Royal Philips . Click here to learn more about the investigation: http://zlk.9nl.com/volcano-volc . Under the terms of the transaction, Volcano shareholders will receive $18.00 in cash for each share of Volcano stock they own. The investigation concerns whether the Board of Volcano breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter ...

      Read Full Article
    7. Philips to acquire Volcano to expand global leadership position in image-guided therapy market

      Philips to acquire Volcano to expand global leadership position in image-guided therapy market

      Royal Philips (NYSE: PHG; AEX: PHIA) and Volcano Corporation (NASDAQ:VOLC), a global leader in catheter-based imaging and measurement solutions for cardiovascular applications, today announced that they have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a tender offer to acquire all of the issued and outstanding shares of Volcano for USD 18.00 per share, or a total equity purchase price of USD 1 billion (approx. EUR 800 million), to be paid in cash upon completion. The board of directors of Volcano has unanimously approved the transaction and recommends the offer to its shareholders ...

      Read Full Article
    8. Covidien Announces Definitive Agreement to Acquire Given Imaging for $860M

      Covidien Announces Definitive Agreement to Acquire Given Imaging for $860M

      Covidien Announces Definitive Agreement to Acquire Given Imaging Advances Covidien strategy to more comprehensively address key specialties and procedures globally Adds Given Imaging’s broad suite of minimally invasive gastrointestinal diagnostic and monitoring solutions Accelerates development of world-class gastrointestinal portfolio focused on serving patient from diagnosis to treatment Accretive to earnings per share beginning in fiscal 2015 Covidien plc (NYSE: COV) and Given Imaging Ltd . (Nasdaq: GIVN) today announced a definitive agreement under which Covidien will acquire all of the outstanding shares of Given Imaging for $30.00 per share in cash, for a total of approximately $860 million, net ...

      Read Full Article
    9. Halliburton acquires distributed acoustic sensing systems provider Optiphase

      Halliburton acquires distributed acoustic sensing systems provider Optiphase

      Halliburton has completed acquisition of the assets of Optiphase, a provider of interferometric fiber optic sensing solutions, including distributed acoustic sensing (DAS) interrogation systems. The terms and cost of the acquisition were not disclosed. DAS technology turns a piece of fiber optic cable, similar to what one would use for cable or telephone service, into a fully distributed noise logging system. When applied to an oil and gas well, operators can tune in to any section of the fiber, and listen to what is happening in their well. Applications are varied, and include stimulation and production monitoring, verification of downhole ...

      Read Full Article
      Mentions: Optiphase Jeff Bush
    10. Abbott to Enter Laser Cataract Surgery Market through $400M Acquisition of OptiMedica

      Abbott to Enter Laser Cataract Surgery Market through $400M Acquisition of OptiMedica

      Abbott (NYSE: ABT ) today announced it has entered into an agreement to purchase OptiMedica Corporation, a privately held, Silicon Valley-based ophthalmic device company. The acquisition will enable Abbott to expand its vision care business into the femtosecond laser-assisted cataract surgery market. Under the terms of the agreement, Abbott will acquire OptiMedica for $250 million , net of cash, plus additional payments totaling up to $150 million upon completion of certain development, regulatory or sales milestones. Currently, most cataract procedures are performed manually, with the surgeon making incisions into the eye by hand. OptiMedica's Catalys ™ Precision Laser System is designed to ...

      Read Full Article
      Mentions: OptiMedica FDA
    11. Terumo Corporation Offers to Invest $640 Million in Olympus Corporation

      Terumo Corporation Offers to Invest $640 Million in Olympus Corporation

      Japan's Terumo Corp. proposes a merger with Olympus Corp., aiming for a buyout to block rival companies' advances. Asian medical device giant Terumo Corp. (TYO:4543) confirmed rumors of a proposed buyout of Olympus (PINK:OCPNY) in the aftermath of a $1.7 billion accounting scandal. Terumo offered a $640 million investment into Olympus, sending OCPYNY shares up 6% to a closing price of $17.44 last night. Terumo confirmed that it had proposed an investment and is looking to form a committee to investigate a joint holding company.

      Read Full Article
    12. Buyout: Terumo aims to merge with a post-scandal Olympus Corp

      Buyout: Terumo aims to merge with a post-scandal Olympus Corp

      Japan's Terumo Corp. proposes a merger with Olympus Corp., aiming for a buyout to block rival companies' advances. Asian medical device giant Terumo Corp. (TYO:4543) confirmed rumors of a proposed buyout of Olympus (PINK:OCPNY) in the aftermath of a $1.7 billion accounting scandal. Terumo offered a $640 million investment into Olympus, sending OCPYNY shares up 6% to a closing price of $17.44 last night. Terumo confirmed that it had proposed an investment and is looking to form a committee to investigate a joint holding company. The move tops that of rival buyer Sony Corp. (TYO ...

      Read Full Article
    13. IDEX buys Precision Photonics in $20M cash deal

      IDEX buys Precision Photonics in $20M cash deal

      IDEX Corporation, the diversified fluidics firm that became a major player in the photonics sector with the $400 million buy-out of CVI Melles Griot last year, has followed up with the acquisition of Boulder-based Precision Photonics. The $20 million cash purchase is confirmation of the company’s promised policy of consolidating the photonics business, as outlined by IDEX’s Mike Cumbo in an interview with optics.org last month. Cumbo, president of IDEX’s optics and photonics business unit, said that the company’s model was to achieve 50% of its total growth through acquisitions, and highlighted light detection and ...

      Read Full Article
    14. Optos Finishes Hunt for OCT Technology – Acquires Instrument Division of OPKO for Potential $38M – The Real Work Starts Now

      Optos Finishes Hunt for OCT Technology – Acquires Instrument Division of OPKO for Potential $38M –  The Real Work Starts Now
      In January 2011 Roy Davis the chief executive of UK ophthalmic company Optos stated he was signaling the next step in his company’s turnaround strategy.  Davis stated he was on the hunt for OCT technology (see reference).   While Davis said, “We wouldn't rule out either buying or licensing the technology but we won't be developing it from scratch", it seemed pretty clear he preferred to acquire the technology.  While there are about 10 ophthalmic OCT companies around the world there are few that would be for sale as companies such as Zeiss, Heidelberg, and Topcon are clearly ...
      Read Full Article
    15. OPKO Announces Sale of Ophthalmic Instrumentation Business

      OPKO Announces Sale of Ophthalmic Instrumentation Business
      OPKO Health, Inc. (NYSE: OPK) has agreed to sell its ophthalmic instrumentation business to OPTOS, Inc., a subsidiary of Optos plc, a leading and rapidly growing medical technology company engaged in the design, development, manufacture and marketing of devices to image the retina of the eye. Optos will pay OPKO $17.5 million in cash at closing, plus future royalties. The transaction has been approved by the Board of Directors of both companies and is expected to close in the fourth quarter of 2011, subject to approval of the shareholders of Optos and customary closing conditions. Optos is acquiring OPKO ...
      Read Full Article
      Mentions: Phillip Frost Optos
    16. Proposed Acquisition of the OCT and ultrasound business and assets of OPKO Health, Inc.

      Proposed Acquisition of the OCT and ultrasound business and assets of OPKO Health, Inc.
      Optos plc (LSE: OPTS), a leading medical retinal imaging company, announces that it has entered into a conditional agreement with OPKO Health, Inc., OPKO Instrumentation, LLC, Ophthalmic Technologies Inc. and OTI (UK) Limited to acquire the assets and business of the instrumentation division of OPKO. OPKO Instrumentation is engaged in the development, manufacture and sale of optical coherence tomography (“OCT”) diagnostic devices and optical ultrasound scanners, each used by the ophthalmic and optometric professions in the diagnosis and management of eye disease and conditions.
      Read Full Article
    17. Optos focused on future targets

      Optos focused on future targets
      The acquisition, Optos’s second in nine months, gives the company access to an additional form of retinal imager. The company will start work on a new device that combines the two companies’ retinal imaging techniques in an effort to move ahead of its rivals. Mr Davis told The Herald buying a business with the optical coherence tomography (OCT) technology provided by Opko was a “dream acquisition”. He added: “This is an important step for us.”
      Read Full Article
      Mentions: Optos Roy Davis
    18. Raytheon quiet on Elcan sell-off rumors

      Raytheon quiet on Elcan sell-off rumors
      Raytheon is refusing to comment on speculation that it is planning to sell its Elcan Optical Technologies division, after Reuters reported that the defense contractor had hired bankers to run an auction process. With expectations of a sharp reduction in military spending in the US, and the impact already being felt as the availability of funding through small business and technology transfer programs is squeezed, defense contractors will be looking to focus on their most profitable business areas.
      Read Full Article
    19. Lantis Laser Signs Definitive Merger Agreement With TAG Minerals

      Lantis Laser Signs Definitive Merger Agreement With TAG Minerals
      Lantis Laser Press Release - Lantis Laser Inc. (OTCQB:LLSR), announced today it has signed the final definitive Agreement to merge with TAG Minerals Inc.In the view of the management of both companies, Lantis' merger with TAG puts the company in the potential position to execute its business model on all fronts. TAG's management believes that with the price of gold breaking through the $1500 an ounce barrier, the timing is good for TAG to gear up and transition to full-scale mining operations in Zimbabwe. TAG has become Lantis' second wholly-owned subsidiary, with Lantis' first wholly-owned subsidiary, Lantis Laser ...
      Read Full Article
    20. Canon announces ophthalmic diagnostics plans following takeover of Optopol

      Canon announces ophthalmic diagnostics plans following takeover of Optopol
      Canon Europe has announced details of its integration with Optopol following the takeover in December 2009. Canon’s aim through the acquisition is to achieve the world’s prime position in the ophthalmic diagnostic equipment market. The combination of the two companies gives a complementary fit in products, technologies and channels. Mr Yoshiyuki Masuko, Senior Director, Medical Systems Division, Canon Europe, said, “Canon welcomes Optopol as a new partner and subsidiary company of the Canon group. The new combination enables Canon to enter the field of Optical Coherence Tomography (OCT), which is expected to undergo significant growth, and we are ...
      Read Full Article
    21. St. Jude Medical Completes Acquisition of LightLab Imaging

      St. Jude Medical Completes Acquisition of LightLab Imaging
      ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today completed the previously announced acquisition of LightLab Imaging, Inc. for approximately $90 million in cash. LightLab is the pioneer and leader in the development of Optical Coherence Tomography (OCT), a high resolution diagnostic coronary imaging technology which aids physicians in the treatment of cardiovascular disease. The acquisition of OCT technology accelerates the expansion of St. Jude Medical’s cardiovascular growth platform by providing the company with a comprehensive product offering that will allow the Company to compete in, and potentially expand, the intravascular ...
      Read Full Article
    22. Lantis Laser Signs Letter of Intent to Merge With Perio-Imaging Inc.

      Lantis Laser Signs Letter of Intent to Merge With Perio-Imaging Inc.
      Lantis Laser Inc. (OTCBB:LLSR) (http://www.lantislaser.com), announced today that it has signed a Letter of Intent to merge with Perio-Imaging Inc., a private New York based company. The merger would be an all stock transaction and closing, among other conditions, would be subject to raising the required funding to complete the proposed merged company's product development program. The name of the new merged company will be announced upon closing.
      Read Full Article
    23. St. Jude Medical to Acquire LightLab Imaging for $90M in Cash

      St. Jude Medical to Acquire LightLab Imaging for $90M in Cash
      St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, and LightLab Imaging, Inc. today announced a definitive agreement under which St. Jude Medical will acquire LightLab, a subsidiary of Goodman Co., Ltd. (JASDAQ: 7535) for approximately $90 million in cash. Acquisition of Optical Coherence Tomography technology provides St. Jude Medical with product platform to compete in and potentially expand $500 million coronary imaging market “We welcome LightLab and its employees to St. Jude Medical.” LightLab is the pioneer and leader in the development of Optical Coherence Tomography (OCT), a high resolution diagnostic coronary imaging technology which aids physicians ...
      Read Full Article
    24. CardioSpectra founders win UT System Chancellor's award for entrepreneurship

      CardioSpectra founders win UT System Chancellor's award for entrepreneurship
      University of Texas System Chancellor Francisco Cigarroa honored three professors within the system — including one in San Antonio — with the 2010 Chancellor’s Entrepreneurship and Innovation Award. Dr. Marc Feldman, associate professor of medicine and engineering at the University of Texas Health Science Center at San Antonio, was one of three professors within the UT System to receive the award. He and Tom Milner, the Marion E. Forsman Centennial Professor in Engineering at the University of Texas at Austin, were recognized for their development of a novel approach applied to cardiovascular imaging. They developed a technology to help cardiologists provide ...
      Read Full Article
    1-24 of 60 1 2 3 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles